Clinical Study of Ligustrazine in Treating Alcohol Addiction

Clinical trial NCT05942352 · UNKNOWN

Trial details

NCT number: NCT05942352
Sponsor: Shenzhen Kangning Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Alcohol Abuse Arteriosclerosis

Start date: 2023-07-28
Primary completion: 2024-07-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.